Autologous bone graft: Is it still the gold standard?
نویسندگان
چکیده
منابع مشابه
Ablative laser resurfacing: is it still the gold standard for facial rejuvenation?
A new era in dermatological cosmetology, especially in the field of nonsurgical skin rejuvenation, started with ablative resurfacing, at first by carbon dioxide laser and later by Er:YAG or their combination. Although ablative lasers result in major improvements in photodamaged skin, the related postoperative recovery time and side effects are currently unacceptable for most patients. During th...
متن کاملDrugs for Parkinson’s disease: levodopa is still the gold standard.
Parkinson's disease (PD) is a global affl iction which occurs in all ethnic groups and socioeconomic classes, with estimated incidences ranging from 16–19 per 100,000 people per year and crude prevalence rates as high as 160 per 100,000 people per year (WHO/WFN 2004). It was recently estimated that there were over 1 million PD patients in Western Europe and the USA in 2005, and this number was ...
متن کاملTransurethral resection of the prostate: still the gold standard.
BACKGROUND In recent times there has been a number of newer methods advocated as treatment for bladder outlet obstruction. Prior to embracing these newer technologies, the authors' experiences with conventional transurethral resection of the prostate should be evaluated and compared with those experienced in the newer modalities. The objective was to determine whether a standard transurethral r...
متن کاملAutogenous bone grafts in oral implantology—is it still a “gold standard”? A consecutive review of 279 patients with 456 clinical procedures
BACKGROUND This study assessed the clinical outcomes of graft success rate and early implant survival rate after preprosthetic alveolar ridge reconstruction with autologous bone grafts. METHODS A consecutive retrospective study was conducted on all patients who were treated at the military outpatient clinic of the Department of Oral and Plastic Maxillofacial Surgery at the military hospital i...
متن کاملAutologous Stem Cell Transplantation in Multiple Myeloma: Is It Still the Right Choice?
Autologous stem cell transplantation (ASCT) is considered the standard of care for multiple myeloma patients aged <65 years with no relevant comorbidities. The addition of proteasome inhibitors and/or immunomodulatory drugs has significantly increased the percentage of patients achieving a complete remission after induction therapy, and these results are maintained after high-dose melphalan (Al...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Injury
سال: 2021
ISSN: 0020-1383
DOI: 10.1016/j.injury.2021.01.043